Adagio Medical Holdings, Inc Common Stock (ADGM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Adagio Medical Holdings, Inc Common Stock (ADGM) has a cash flow conversion efficiency ratio of -0.334x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.14 Million) by net assets ($12.40 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Adagio Medical Holdings, Inc Common Stoc to measure how many days the company can operate on defensive assets alone.
Adagio Medical Holdings, Inc Common Stock - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Adagio Medical Holdings, Inc Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Adagio Medical Holdings, Inc Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Adagio Medical Holdings, Inc Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Signet Industries Limited
NSE:SIGIND
|
0.045x |
|
Vertice Bhd
KLSE:7240
|
-0.013x |
|
Legend Power Systems Inc
V:LPS
|
-0.067x |
|
Salona Cotspin Limited
NSE:SALONA
|
0.248x |
|
Huddlestock Fintech As
OL:HUDL
|
-0.127x |
|
ELL ENVIRON.HLDGS HD-0001
F:6EL
|
N/A |
|
Neuroscientific Biopharmaceuticals Ltd
AU:NSB
|
-0.029x |
|
Betonjaya Manunggal Tbk
JK:BTON
|
0.062x |
Annual Cash Flow Conversion Efficiency for Adagio Medical Holdings, Inc Common Stock (2021–2025)
The table below shows the annual cash flow conversion efficiency of Adagio Medical Holdings, Inc Common Stock from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Adagio Medical Holdings, Inc Common Stoc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $12.40 Million | $-19.01 Million | -1.533x | -3.63% |
| 2024-12-31 | $19.91 Million | $-29.46 Million | -1.479x | -861.43% |
| 2023-12-31 | $-132.02 Million | $-25.65 Million | 0.194x | -16.88% |
| 2022-12-31 | $-95.88 Million | $-22.41 Million | 0.234x | -12.08% |
| 2021-12-31 | $-72.62 Million | $-19.31 Million | 0.266x | -- |
About Adagio Medical Holdings, Inc Common Stock
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLA… Read more